• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期糖尿病肾病患者透析方式的选择

Selection of dialysis methods for end-stage kidney disease patients with diabetes.

作者信息

Hu Yao-Hua, Liu Ya-Li, Meng Ling-Fei, Zhang Yi-Xian, Cui Wen-Peng

机构信息

Department of Nephrology, The Second Hospital of Jilin University, Changchun 130041, Jilin Province, China.

出版信息

World J Diabetes. 2024 Sep 15;15(9):1862-1873. doi: 10.4239/wjd.v15.i9.1862.

DOI:10.4239/wjd.v15.i9.1862
PMID:39280188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11372645/
Abstract

The increasing prevalence of diabetes has led to a growing population of end-stage kidney disease (ESKD) patients with diabetes. Currently, kidney transplantation is the best treatment option for ESKD patients; however, it is limited by the lack of donors. Therefore, dialysis has become the standard treatment for ESKD patients. However, the optimal dialysis method for diabetic ESKD patients remains controversial. ESKD patients with diabetes often present with complex conditions and numerous complications. Furthermore, these patients face a high risk of infection and technical failure, are more susceptible to malnutrition, have difficulty establishing vascular access, and experience more frequent blood sugar fluctuations than the general population. Therefore, this article reviews nine critical aspects: Survival rate, glucose metabolism disorder, infectious complications, cardiovascular events, residual renal function, quality of life, economic benefits, malnutrition, and volume load. This study aims to assist clinicians in selecting individualized treatment methods by comparing the advantages and disadvantages of hemodialysis and peritoneal dialysis, thereby improving patients' quality of life and survival rates.

摘要

糖尿病患病率的不断上升导致患有糖尿病的终末期肾病(ESKD)患者群体日益壮大。目前,肾移植是ESKD患者的最佳治疗选择;然而,它受到供体短缺的限制。因此,透析已成为ESKD患者的标准治疗方法。然而,糖尿病ESKD患者的最佳透析方式仍存在争议。糖尿病ESKD患者往往病情复杂且并发症众多。此外,这些患者面临感染和技术失败的高风险,更容易出现营养不良,建立血管通路困难,并且血糖波动比普通人群更频繁。因此,本文综述了九个关键方面:生存率、糖代谢紊乱、感染性并发症、心血管事件、残余肾功能、生活质量、经济效益、营养不良和容量负荷。本研究旨在通过比较血液透析和腹膜透析的优缺点,协助临床医生选择个体化的治疗方法,从而提高患者的生活质量和生存率。

相似文献

1
Selection of dialysis methods for end-stage kidney disease patients with diabetes.终末期糖尿病肾病患者透析方式的选择
World J Diabetes. 2024 Sep 15;15(9):1862-1873. doi: 10.4239/wjd.v15.i9.1862.
2
Diabetes mellitus and dialysis.糖尿病与透析
Minerva Urol Nefrol. 2004 Sep;56(3):289-303.
3
Hemodialysis血液透析
4
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
5
Renal Replacement Therapy For Elderly Patients with ESKD Through Shared Decision-Making.通过共同决策为老年终末期肾病患者提供肾脏替代治疗
Electrolyte Blood Press. 2023 Jun;21(1):1-7. doi: 10.5049/EBP.2023.21.1.1. Epub 2023 Jun 27.
6
Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.全球终末期肾病的流行病学和肾脏替代治疗的差异。
Am J Nephrol. 2021;52(2):98-107. doi: 10.1159/000514550. Epub 2021 Mar 22.
7
[Peritoneal dialysis in the aged].[老年人的腹膜透析]
Med Pregl. 1999 Sep-Oct;52(9-10):369-74.
8
Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.在南非,长期接受 CAPD 的黑人 ESKD 患者中,动脉粥样硬化性血管疾病更为普遍。
BMC Nephrol. 2019 Oct 30;20(1):399. doi: 10.1186/s12882-019-1583-8.
9
End-Stage Kidney Disease in Patients With Autosomal Dominant Polycystic Kidney Disease: A 12-Year Study Based on the Canadian Organ Replacement Registry.常染色体显性多囊肾病患者的终末期肾病:一项基于加拿大器官替代登记处的12年研究
Can J Kidney Health Dis. 2018 Jun 11;5:2054358118778568. doi: 10.1177/2054358118778568. eCollection 2018.
10
Mortality rate of end-stage kidney disease patients in Taiwan.台湾地区终末期肾病患者的死亡率。
J Formos Med Assoc. 2022 Feb;121 Suppl 1:S12-S19. doi: 10.1016/j.jfma.2021.12.015. Epub 2021 Dec 29.

引用本文的文献

1
Enhanced prognostic value of a composite nutritional-inflammatory index (P-CONUT) for predicting mortality risk in patients initiating peritoneal dialysis.综合营养-炎症指数(P-CONUT)对预测开始腹膜透析患者死亡风险的预后价值增强。
PLoS One. 2025 May 22;20(5):e0323318. doi: 10.1371/journal.pone.0323318. eCollection 2025.
2
Optimizing dialysis modalities for diabetic end-stage kidney disease: A focus on personalized care and resource-limited settings.优化糖尿病终末期肾病的透析方式:关注个性化护理和资源有限的环境。
World J Diabetes. 2025 Mar 15;16(3):100592. doi: 10.4239/wjd.v16.i3.100592.
3
The association between the atherogenic index of plasma and all-cause mortality in patients undergoing peritoneal dialysis: a multicenter cohort study.血浆致动脉粥样硬化指数与腹膜透析患者全因死亡率之间的关联:一项多中心队列研究。
Lipids Health Dis. 2025 Mar 13;24(1):91. doi: 10.1186/s12944-025-02510-z.
4
What is the optimal dialysis method for diabetic patients with end stage kidney disease?终末期肾病糖尿病患者的最佳透析方法是什么?
World J Diabetes. 2024 Dec 15;15(12):2272-2275. doi: 10.4239/wjd.v15.i12.2272.

本文引用的文献

1
Incremental peritoneal dialysis and survival outcomes: a propensity-matched cohort study.间歇性腹膜透析与生存结局:一项倾向匹配队列研究。
J Nephrol. 2023 Sep;36(7):1907-1919. doi: 10.1007/s40620-023-01735-4. Epub 2023 Aug 21.
2
The Pillars for Renal Disease Treatment in Patients with Type 2 Diabetes.2型糖尿病患者肾脏疾病治疗的支柱
Pharmaceutics. 2023 Apr 27;15(5):1343. doi: 10.3390/pharmaceutics15051343.
3
Comparison of quality of life in patients with advanced chronic kidney disease undergoing haemodialysis, peritoneal dialysis and conservative management in Johannesburg, South Africa: a cross-sectional, descriptive study.南非约翰内斯堡地区接受血液透析、腹膜透析和保守治疗的晚期慢性肾脏病患者的生活质量比较:一项横断面、描述性研究。
BMC Psychol. 2023 May 8;11(1):151. doi: 10.1186/s40359-023-01196-1.
4
Inferior Nutritional Status Significantly Differentiates Dialysis Patients with Type 1 and Type 2 Diabetes.营养状况不佳可显著区分 1 型和 2 型糖尿病透析患者。
Nutrients. 2023 Mar 23;15(7):1549. doi: 10.3390/nu15071549.
5
US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2022年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2023 Mar;81(3 Suppl1):A8-A11. doi: 10.1053/j.ajkd.2022.12.001.
6
Surveillance of hemodialysis related infections: a prospective multicenter study.血液透析相关感染的监测:一项前瞻性多中心研究。
Sci Rep. 2022 Dec 23;12(1):22240. doi: 10.1038/s41598-022-24820-3.
7
Quality of Life of Hemodialysis Patients in Greece: Associations with Socio-Economic, Anthropometric and Nutritional Factors.希腊血液透析患者的生活质量:与社会经济、人体测量和营养因素的关系。
Int J Environ Res Public Health. 2022 Nov 21;19(22):15389. doi: 10.3390/ijerph192215389.
8
Impact of fluid overload on blood pressure variability in patients on peritoneal dialysis.液体超负荷对腹膜透析患者血压变异性的影响。
Ren Fail. 2022 Dec;44(1):2066-2072. doi: 10.1080/0886022X.2022.2148535.
9
Hemodialysis and Peritoneal Dialysis in Germany from a Health Economic View-A Propensity Score Matched Analysis.德国的血液透析和腹膜透析的卫生经济观点——倾向评分匹配分析。
Int J Environ Res Public Health. 2022 Oct 27;19(21):14007. doi: 10.3390/ijerph192114007.
10
Causes of Hospitalization among End-Stage Kidney Disease Cohort before and after Hemodialysis.终末期肾病血液透析前后住院原因的队列研究。
Int J Environ Res Public Health. 2022 Aug 18;19(16):10253. doi: 10.3390/ijerph191610253.